UPDATE: Citi Raises Praxair's PT

According to a research report published this morning, Citi has increased Praxair's PX PT from $120 to $130. In the report, Citi said, "A better than expected 1Q12 EPS highlights PX's operational consistency, with steady volume growth of 4% and robust operating margins of 22%. Results in North America were particularly impressive as volumes were strong (+7%), compared to its major competitor APD which reported weaker volumes. New plant startups will increasingly support volumes & EPS growth, with new projects contributing $800mm of sales in 2013. We remain fans of PX's strong execution, and raise our TP to $130." Citi maintains its Buy rating on Praxair, which closed yesterday at $113.77.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorPrice TargetAnalyst RatingsCiti
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!